• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿肾上腺皮质肿瘤的症状持续时间延长及逐渐进展的可能性:MET研究的观察结果

Prolonged symptom duration and the potential for gradual progression in pediatric adrenocortical tumors: observations from the MET studies.

作者信息

Kuhlen Michaela, Wudy Stefan A, Baumann Clara, Vokuhl Christian, Hartmann Michaela F, Kunstreich Marina, Claus Rainer, Redlich Antje

机构信息

Pediatrics and Adolescent Medicine, Faculty of Medicine, 531257 University of Augsburg , Augsburg, Germany.

Bavarian Cancer Research Center (BZKF), Augsburg, Germany.

出版信息

J Pediatr Endocrinol Metab. 2025 Jun 30;38(9):931-938. doi: 10.1515/jpem-2025-0198. Print 2025 Sep 25.

DOI:10.1515/jpem-2025-0198
PMID:40577853
Abstract

OBJECTIVES

To explore the clinical spectrum and symptom duration in pediatric adrenocortical tumors (pACTs), with a focus on identifying cases that may reflect gradual tumor progression.

METHODS

We retrospectively analyzed data from 110 pediatric patients with pACTs enrolled in the German Pediatric Oncology Hematology-Malignant Endocrine Tumor (GPOH-MET) studies (1997-2022). Endocrine symptom duration, histopathological classification, and clinical outcomes were assessed. Patients with symptom durations ≥2 standard deviations (SDs) from the mean were defined as outliers and evaluated for potential progression.

RESULTS

The cohort included 31 patients with adrenocortical adenomas (ACAs), 12 with tumors of uncertain malignant potential (ACx), and 67 with adrenocortical carcinomas (ACCs). Seven patients (6.4 %) showed markedly prolonged symptom duration, including four with ACC. One representative case demonstrated a nearly 5-year course from initial androgen excess to metastatic ACC, with evolving biochemical features and a diagnostic urinary steroid profile indicative of adrenal tumor activity.

CONCLUSIONS

A small subset of pACTs may present with prolonged endocrine symptoms, possibly reflecting gradual tumor evolution. While molecular validation is lacking, these findings support the need for early recognition and further research into the natural history of pACTs.

摘要

目的

探讨儿童肾上腺皮质肿瘤(pACTs)的临床谱和症状持续时间,重点是识别可能反映肿瘤逐渐进展的病例。

方法

我们回顾性分析了110例纳入德国儿科肿瘤血液学 - 恶性内分泌肿瘤(GPOH - MET)研究(1997 - 2022年)的儿童pACTs患者的数据。评估内分泌症状持续时间、组织病理学分类和临床结局。症状持续时间≥平均水平2个标准差(SDs)的患者被定义为异常值,并评估其潜在进展情况。

结果

该队列包括31例肾上腺皮质腺瘤(ACAs)患者、12例恶性潜能不确定肿瘤(ACx)患者和67例肾上腺皮质癌(ACCs)患者。7例患者(6.4%)症状持续时间明显延长,其中4例为ACC。1例代表性病例展示了从最初雄激素过多到转移性ACC的近5年病程,伴有不断演变的生化特征以及诊断性尿类固醇谱,提示肾上腺肿瘤活动。

结论

一小部分pACTs可能表现为内分泌症状延长,这可能反映肿瘤逐渐演变。虽然缺乏分子验证,但这些发现支持早期识别以及对pACTs自然史进行进一步研究的必要性。

相似文献

1
Prolonged symptom duration and the potential for gradual progression in pediatric adrenocortical tumors: observations from the MET studies.小儿肾上腺皮质肿瘤的症状持续时间延长及逐渐进展的可能性:MET研究的观察结果
J Pediatr Endocrinol Metab. 2025 Jun 30;38(9):931-938. doi: 10.1515/jpem-2025-0198. Print 2025 Sep 25.
2
Adrenocortical carcinoma survival gene HMMR was identified as being targeted by fluorouracil and epirubicin using a gene coexpression network-based drug repositioning strategy.使用基于基因共表达网络的药物重新定位策略,肾上腺皮质癌生存基因HMMR被确定为氟尿嘧啶和表柔比星的作用靶点。
Sci Rep. 2025 Jul 17;15(1):25912. doi: 10.1038/s41598-025-10452-w.
3
Serum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study.血清类固醇谱分析在肾上腺皮质癌诊断中的应用:一项前瞻性队列研究
J Clin Endocrinol Metab. 2025 Mar 17;110(4):1177-1186. doi: 10.1210/clinem/dgae604.
4
Pediatric adrenal cortical carcinomas: Histopathological criteria and clinical trials. A systematic review.
Contemp Clin Trials. 2016 Sep;50:37-44. doi: 10.1016/j.cct.2016.07.011. Epub 2016 Jul 14.
5
Myxoid adrenocortical adenoma with pseudoglandular pattern: A clinicopathological study of a rare histologic variant and its diagnostic challenges.具有假腺管样结构的黏液样肾上腺皮质腺瘤:一种罕见组织学变异型的临床病理研究及其诊断挑战
Ann Diagn Pathol. 2025 Dec;79:152527. doi: 10.1016/j.anndiagpath.2025.152527. Epub 2025 Jul 8.
6
YAP1 is a prognostic marker and its inhibition reduces tumor progression in adrenocortical tumors.YAP1是一种预后标志物,抑制它可降低肾上腺皮质肿瘤的肿瘤进展。
J Clin Endocrinol Metab. 2025 Jan 10. doi: 10.1210/clinem/dgaf013.
7
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.大剂量化疗及自体造血干细胞救援用于高危神经母细胞瘤患儿
Cochrane Database Syst Rev. 2015 Oct 5;2015(10):CD006301. doi: 10.1002/14651858.CD006301.pub4.
8
Topical corticosteroids for dry eye.局部皮质类固醇治疗干眼。
Cochrane Database Syst Rev. 2022 Oct 21;10(10):CD015070. doi: 10.1002/14651858.CD015070.pub2.
9
Differentiating between adrenocortical carcinoma and pheochromocytoma by a CT-based radiomics model: a multicenter retrospective study.基于CT的影像组学模型鉴别肾上腺皮质癌和嗜铬细胞瘤:一项多中心回顾性研究
BMC Med Imaging. 2025 Aug 1;25(1):310. doi: 10.1186/s12880-025-01842-7.
10
Prognostic value of the Weiss and Wieneke (AFIP) scoring systems in pediatric ACC - a mini review.Weiss和Wieneke(AFIP)评分系统在儿童肾上腺皮质癌中的预后价值——一项小型综述
Endocr Relat Cancer. 2023 Mar 8;30(4). doi: 10.1530/ERC-22-0259. Print 2023 Apr 1.

本文引用的文献

1
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.从隐窝到癌症:结直肠癌发生和治疗策略的整体观点。
Int J Mol Sci. 2024 Aug 30;25(17):9463. doi: 10.3390/ijms25179463.
2
Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery.小儿肾上腺皮质癌:诊断与治疗要点及未来探索方向
Cancer Manag Res. 2024 Sep 7;16:1141-1153. doi: 10.2147/CMAR.S348725. eCollection 2024.
3
The Endocrine Phenotype Induced by Pediatric Adrenocortical Tumors Is Age- and Sex-Dependent.
J Clin Endocrinol Metab. 2024 Jul 12;109(8):2053-2060. doi: 10.1210/clinem/dgae073.
4
Advances in translational research of the rare cancer type adrenocortical carcinoma.罕见癌症类型肾上腺皮质癌的转化研究进展。
Nat Rev Cancer. 2023 Dec;23(12):805-824. doi: 10.1038/s41568-023-00623-0. Epub 2023 Oct 19.
5
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.欧洲内分泌学会与欧洲肾上腺肿瘤研究网络合作制定的关于肾上腺意外瘤处理的临床实践指南。
Eur J Endocrinol. 2023 Jul 20;189(1):G1-G42. doi: 10.1093/ejendo/lvad066.
6
Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.小儿肾上腺皮质肿瘤:三种组织病理学评分系统比较的研究。
Endocr Pathol. 2023 Jun;34(2):213-223. doi: 10.1007/s12022-023-09767-z. Epub 2023 May 9.
7
Outcome for Pediatric Adreno-Cortical Tumors Is Best Predicted by the COG Stage and Five-Item Microscopic Score-Report from the German MET Studies.儿童肾上腺皮质肿瘤的预后最好通过儿童肿瘤协作组(COG)分期和德国MET研究的五项微观评分报告来预测。
Cancers (Basel). 2022 Dec 30;15(1):225. doi: 10.3390/cancers15010225.
8
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?儿童与成人肾上腺皮质癌的不同治疗方法:是否到了分享指南的时候?
Endocrine. 2021 Dec;74(3):475-477. doi: 10.1007/s12020-021-02874-z. Epub 2021 Sep 24.
9
Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations.儿童和青少年肾上腺皮质肿瘤:EXPeRT/PARTNER 诊断和治疗建议。
Pediatr Blood Cancer. 2021 Jun;68 Suppl 4:e29025. doi: 10.1002/pbc.29025.
10
Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries.利用多个组合诱变文库对 TP53 功能丧失进行综合评估。
Sci Rep. 2020 Nov 23;10(1):20368. doi: 10.1038/s41598-020-74892-2.